(c) Patient Race/Ethnicity
Participants lost an average of 14.9% of their body weight over 68 weeks compared to merely 0.4% with placebo
We use InBody scans at baseline and throughout your program so we can see what kind of weight youre actually losing
Hseli, Jakob Schattenfroh, Tom Meyer, Paul Spiesecke, Tobias Puengel, Florian Roner, Bernhard Gebauer, Raphael Mohr, Mnevver Demir, Frank Tacke, Ingolf Sack, Rolf Reiter Journal of the Mechanical Behavior of Biomedical Materials .2026
[2] [1] It belongs to a novel class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists
Once ingested, it expands in the stomach by absorbing water, which may create a sensation of fullness and reduce overall calorie intake